Track topics on Twitter Track topics that are important to you
NEURONAX is a privately-held biopharmaceutical company focusing on the development and discovery of therapeutic approaches to treat central nervous system disorders.
Combining an expertise in the development of candidate-drugs and know-how in cell-based assays, NEURONAX builds a well balanced portfolio of compounds and technologies implied in neurorepair. Moreover, the original platform of NEURONAX allows the enrichment of its portfolio of products and is also proposed outside in the form of contracts of service or contracts of research.
NEURONAX aims at forming strategic alliances with partners and establishes preclinical "proof-of-concept" and out-licenses agreements with biotechnology and pharmaceutical companies.
Phone: +33 473 178 388
Fax: +33 473 178 389
NEURONAX is a privately-held biopharmaceutical company focusing on the development and discovery of therapeutic approaches to treat central nervous system disorders. Combining an expertise in the dev...
We have published hundreds of Neuronax SAS news stories on BioPortfolio along with dozens of Neuronax SAS Clinical Trials and PubMed Articles about Neuronax SAS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neuronax SAS Companies in our database. You can also find out about relevant Neuronax SAS Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...